For research use only  ·  Not for human or veterinary use  ·  No dosing or therapeutic claims

Certificates of analysis

COAs

Issued third-party certificates are shown below with lot, report number, purity, and content. Every listed size also has a certificate slot in the library. When a laboratory issues a certificate for a lot, it is linked as “View COA.” Until then, the slot reads “COA pending, published after third-party testing.”

Issued certificates

Third-party certificates from Premier Analytical Sciences. Numbers are published as the laboratory reported them. Open the certificate or verify the report with the lab.

Certificate of analysis for Tesamorelin 10 mg, lot 200826

Premier Analytical Sciences

Tesamorelin

10 mg

Lot
200826
Report
PAS-2026-6934
Purity
99.08%
Content
11.25 mg (112.5% of label)
Identity
Conforms
Issued
October 28, 2026
Certificate of analysis for Retatrutide 30 mg, lot 2745-926

Premier Analytical Sciences

Retatrutide

30 mg

Lot
2745-926
Report
PAS-2026-4442
Purity
99.71%
Content
26.83 mg (89.4% of label)
Identity
Conforms
Issued
October 28, 2026
Certificate of analysis for KLOW 80 mg, lot 153257-926

Premier Analytical Sciences

KLOW

80 mg

GHK-Cu 50 mg / BPC-157 10 mg / TB-500 10 mg / KPV 10 mg

Lot
153257-926
Report
PAS-2026-2997
Purity
99.89%
Content
78.79 mg total (98.5% of label)
Identity
Conforms
Issued
October 28, 2026

COA library

ProductSizeLotCertificate
Semax5 mgSI-SMX-5-2611-001COA pending, published after third-party testing
Semax10 mgSI-SMX-10-2611-001COA pending, published after third-party testing
Semax30 mgSI-SMX-30-2611-001COA pending, published after third-party testing
MOTS-c5 mgSI-MOT-5-2611-001COA pending, published after third-party testing
MOTS-c10 mgSI-MOT-10-2611-001COA pending, published after third-party testing
MOTS-c20 mgSI-MOT-20-2611-001COA pending, published after third-party testing
MOTS-c30 mgSI-MOT-30-2611-001COA pending, published after third-party testing
GHK-Cu100 mgSI-GHK-100-2611-001COA pending, published after third-party testing
Tesamorelin5 mgSI-TES-5-2611-001COA pending, published after third-party testing
Tesamorelin10 mg200826View COA
Tesamorelin20 mgSI-TES-20-2611-001COA pending, published after third-party testing
CJC-1295 (no DAC) + Ipamorelin10 mgSI-CJI-10-2611-001COA pending, published after third-party testing
CJC-1295 (DAC)5 mgSI-CJD-5-2611-001COA pending, published after third-party testing
CJC-1295 (DAC)10 mgSI-CJD-10-2611-001COA pending, published after third-party testing
CJC-1295 (no DAC)5 mgSI-CJC-5-2611-001COA pending, published after third-party testing
CJC-1295 (no DAC)10 mgSI-CJC-10-2611-001COA pending, published after third-party testing
Sermorelin5 mgSI-SRM-5-2611-001COA pending, published after third-party testing
Sermorelin10 mgSI-SRM-10-2611-001COA pending, published after third-party testing
Ipamorelin5 mgSI-IPA-5-2611-001COA pending, published after third-party testing
Ipamorelin10 mgSI-IPA-10-2611-001COA pending, published after third-party testing
KLOW80 mg153257-926View COA
GLOW70 mgSI-GLW-70-2611-001COA pending, published after third-party testing
KPV5 mgSI-KPV-5-2611-001COA pending, published after third-party testing
KPV10 mgSI-KPV-10-2611-001COA pending, published after third-party testing
KPV30 mgSI-KPV-30-2611-001COA pending, published after third-party testing
SS-3110 mgSI-SS3-10-2611-001COA pending, published after third-party testing
Tirzepatide10 mgSI-TRZ-10-2611-001COA pending, published after third-party testing
Tirzepatide15 mgSI-TRZ-15-2611-001COA pending, published after third-party testing
Tirzepatide20 mgSI-TRZ-20-2611-001COA pending, published after third-party testing
Tirzepatide30 mgSI-TRZ-30-2611-001COA pending, published after third-party testing
Retatrutide10 mgSI-RET-10-2611-001COA pending, published after third-party testing
Retatrutide15 mgSI-RET-15-2611-001COA pending, published after third-party testing
Retatrutide20 mgSI-RET-20-2611-001COA pending, published after third-party testing
Retatrutide30 mg2745-926View COA
Retatrutide40 mgSI-RET-40-2611-001COA pending, published after third-party testing
PT-1415 mgSI-PT1-5-2611-001COA pending, published after third-party testing
PT-14110 mgSI-PT1-10-2611-001COA pending, published after third-party testing
BPC-1575 mgSI-BPC-5-2611-001COA pending, published after third-party testing
BPC-15710 mgSI-BPC-10-2611-001COA pending, published after third-party testing
BPC-15720 mgSI-BPC-20-2611-001COA pending, published after third-party testing
BPC-15730 mgSI-BPC-30-2611-001COA pending, published after third-party testing
TB-5005 mgSI-TB5-5-2611-001COA pending, published after third-party testing
TB-50010 mgSI-TB5-10-2611-001COA pending, published after third-party testing
TB-50020 mgSI-TB5-20-2611-001COA pending, published after third-party testing
NAD+500 mgSI-NAD-500-2611-001COA pending, published after third-party testing
BPC-157 + TB-50010 mgSI-BTB-10-2611-001COA pending, published after third-party testing
BPC-157 + TB-50020 mgSI-BTB-20-2611-001COA pending, published after third-party testing
Kisspeptin5 mgSI-KIS-5-2611-001COA pending, published after third-party testing
Melanotan II10 mgSI-MT2-10-2611-001COA pending, published after third-party testing
Selank5 mgSI-SLK-5-2611-001COA pending, published after third-party testing
Selank10 mgSI-SLK-10-2611-001COA pending, published after third-party testing
Selank30 mgSI-SLK-30-2611-001COA pending, published after third-party testing
Semaglutide5 mgSI-SMG-5-2611-001COA pending, published after third-party testing
Semaglutide10 mgSI-SMG-10-2611-001COA pending, published after third-party testing
Semaglutide15 mgSI-SMG-15-2611-001COA pending, published after third-party testing
Semaglutide20 mgSI-SMG-20-2611-001COA pending, published after third-party testing
Semaglutide30 mgSI-SMG-30-2611-001COA pending, published after third-party testing
Epithalon5 mgSI-EPI-5-2611-001COA pending, published after third-party testing
Epithalon10 mgSI-EPI-10-2611-001COA pending, published after third-party testing
Epithalon20 mgSI-EPI-20-2611-001COA pending, published after third-party testing
BAC Water10 mLSI-BAC-10ML-2611-001COA pending, published after third-party testing